Evolent Health, Inc. Net Income Loss

• Evolent Health, Inc. showed a decrease of -767.4% in Net Income Loss from 2024 to 2025.
• This data is from Evolent Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 13 years of available data (2013 to 2025), Evolent Health, Inc.'s Net Income Loss has declined by 2,769.5%.
• Historical annual values: Fiscal year 2025: -$534.51 million | Fiscal year 2024: -$61.62 million | Fiscal year 2023: -$113.04 million | Fiscal year 2022: -$19.16 million | Fiscal year 2021: -$37.60 million | Fiscal year 2020: -$334.25 million | Fiscal year 2019: -$301.97 million | Fiscal year 2018: -$52.66 million | Fiscal year 2017: -$60.67 million | Fiscal year 2016: -$159.74 million | Fiscal year 2015: $332.49 million | Fiscal year 2014: -$25.25 million | Fiscal year 2013: $20.02 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026